ABPA PATIENTS: 3 YEARS FOLLOW UP - Vienna 2024

It's better to be alone than in bad company: the impact of comorbidities on airways disease progression and management

Chair(s): Gert-Jan Braunstahl, Marcin Maciej Kurowski

Session type: Poster session

ABPA PATIENTS: 3 YEARS FOLLOW UP

Francesco Bini

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Association between Diabetes, Glycemic Control, and All-Cause and Cardiovascular Mortality in Asthmatic Adults

Jun Wen

Abstract

Impact of comorbidities on baseline characteristics in severe asthmatics in the German Asthma Net (GAN)

Slagjana Stoshikj

Poster

Abstract

Characteristics of asthma in patients with NSAID hypersensitivity

Elif Naz Sancar

Poster

Abstract

Efficacy of Mepolizumab in a cohort of patiens with severe eosinophilic asthma and bronchiectasis after 6 years of treatment: a single centre study

Gerardo Nazzaro

Poster

Abstract

The impact of adipose eosinophils on diet-induced airway hyperresponsiveness in mice

Becky Proskocil

Poster

Abstract

ABPA PATIENTS: 3 YEARS FOLLOW UP

Francesco Bini

Poster

Abstract

Baseline characteristics of patients with chronic rhinosinusitis with nasal polyps and coexisting asthma initiating dupilumab in the AROMA global registry

Juby Anne Jacob-nara

Poster

Abstract

Unveiling inflammatory patterns in chronic rhinosinusitis and allergy: harnessing algorithmic approaches via mass cytometry

Fana Alem Kidane

Poster

Abstract

The triple type 2 signature is associated to asthma severity and comorbidity with nasal polyps

Jose Antonio Castillo Vizuete

Abstract

HLA-DR immunopeptidomics on cells from bronchoalveolar lavage in early rheumatoid arthritis

Benedikt Z?hrer

Poster

Abstract

Nasal polyposis and response to asthma biologics in real-life: insights from the Belgian Severe Asthma Registry.

Femke Demolder

Poster

Abstract

Eosinophil extracellular traps in allergic bronchopulmonary aspergillosis airways

Xi Chen

Abstract

Blood leukocyte characterisation in Eosinophilic Granulomatosis with Polyangiitis (EGPA)

Rebecca Dale

Poster

Abstract

Asthmatic patients with normal body mass index and high body fat percentage

Masako To

Poster

Abstract

Effect of Hormonal fluctuations on asthma and rhinitis during the menstrual cycle

Samia Aissani

Poster

Abstract

Predictive factors of favorable outcome for mepolizumab and corticosteroid treatment to for eosinophilic granulomatosis with polyangiitis(EGPA)

Ryuta Tsuzuki

Poster

Abstract

An Asthma-COPD Overlap Mouse Model Establishment

Zhimin Zeng

Poster

Abstract

IL-33 substantially initiates and promotes EGPA development via alteration in pulmonary immune microenvironments

Lingna Xue

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}